Abstract
We tested monoclonal IgM anti‐GM1 and asialo‐GM1 antibodies from 6 patients with chronic motor neuropathies for binding to lipopolysccharides (LPS) from three strains of Campylobacter jejuni. Four of the 6 patients showed strong reactivity with LPS from at least one of the three C. jejuni strains tested as shown by enzyme‐linked immunosorbent assay or western blot. Preabsorption with GM1 or asialo‐GM1, or blocking with cholera toxin, prevented antibody binding to LPS. These studies indicate that human anti‐GM1 or anti–asialo‐GM1 antibodies cross‐react with LPS from certain strains of C. jejuni, and that bacterial LPS might provide antigenic stimuli for the activation of B cells expressing anti‐GM1 antibodies.
| Original language | English |
|---|---|
| Pages (from-to) | 698-703 |
| Number of pages | 6 |
| Journal | Annals of Neurology |
| Volume | 35 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Jan 1994 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Monoclonal IgM antibodies to GM1 and asialo‐GM1 in chronic neuropathies cross‐react with Compylobacter jejuni lipopolysaccharides'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver